Akbulut, S. Et Al. 2020. Letter to the Editor: Comment on Alpha-Fetoprotein Decrease From > 1,000 to < 500 ng/mL in Patients With Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes. HEPATOLOGY , vol.72, no.6 , 2242-2243.

Akbulut, S., Sahin, T., & Yilmaz, S., (2020). Letter to the Editor: Comment on Alpha-Fetoprotein Decrease From > 1,000 to < 500 ng/mL in Patients With Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes. HEPATOLOGY , vol.72, no.6, 2242-2243.

Akbulut, AHMET, Tt Sahin, And SEZAİ YILMAZ. "Letter to the Editor: Comment on Alpha-Fetoprotein Decrease From > 1,000 to < 500 ng/mL in Patients With Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes," HEPATOLOGY , vol.72, no.6, 2242-2243, 2020

Akbulut, AHMET S. Et Al. "Letter to the Editor: Comment on Alpha-Fetoprotein Decrease From > 1,000 to < 500 ng/mL in Patients With Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes." HEPATOLOGY , vol.72, no.6, pp.2242-2243, 2020

Akbulut, S. Sahin, T. And Yilmaz, S. (2020) . "Letter to the Editor: Comment on Alpha-Fetoprotein Decrease From > 1,000 to < 500 ng/mL in Patients With Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes." HEPATOLOGY , vol.72, no.6, pp.2242-2243.

@article{article, author={AHMET SAMİ AKBULUT Et Al. }, title={Letter to the Editor: Comment on Alpha-Fetoprotein Decrease From > 1,000 to < 500 ng/mL in Patients With Hepatocellular Carcinoma Leads to Improved Posttransplant Outcomes}, journal={HEPATOLOGY}, year=2020, pages={2242-2243} }